Clinical Trial Update: A Feasibility Study for Convernsion Therapy Using S1/Paclitaxel Chemotherapy Plus Apatinib in ELM Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase 2 feasibility trial investigates conversion therapy using S-1/Paclitaxel chemotherapy plus apatinib in gastric cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Apatinib (apatinib)
• PACLITAXEL (PACLITAXEL)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: The First Affiliated Hospital of Zhejiang Chinese Medical University | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN